Publication search
with desformylflustrabromine (dFBr) as keyword
Weggel, Loni A Pandya, Anshul A
Published in
Molecules (Basel, Switzerland)
Neuronal nicotinic acetylcholine receptors are cell membrane-bound ion channels that are widely distributed in the central nervous system. The α4β2 subtype of neuronal nicotinic acetylcholine receptor plays an important role in modulating the signaling pathways for pain. Previous studies have shown that agonists, partial agonists, and positive allo...
Deba, Farah Ramos, Kara Vannoy, Matthew Munoz, Kemburli Akinola, Lois S. Damaj, M. Imad Hamouda, Ayman K.
Published in
Molecules
Neuronal nicotinic acetylcholine receptor (nAChR)-based therapeutics are sought as a potential alternative strategy to opioids for pain management. In this study, we examine the antinociceptive effects of 3-(2-chlorophenyl)-5-(5-methyl-1-(piperidin-4-yl)-1 H -pyrazol-4-yl)isoxazole (CMPI), a novel positive allosteric modulator (PAM), with preferent...
Mitra, Swarup Mucha, Mckenzie Khatri, Shailesh N. Glenon, Richard Schulte, Marvin K. Bult-Ito, Abel
Published in
Frontiers in Behavioral Neuroscience
Nicotinic α4β2 receptors are the most abundant subtypes of nicotinic acetylcholine receptors (nAChRs) expressed in brain regions implicated in obsessive compulsive disorder (OCD). These receptors are known to modify normal and addictive behaviors by modulating neuronal excitability. Desformylflustrabromine (dFBr) is a novel, positive allosteric mod...